Novo Nordisk Still Accepting Community Star Entries

Share Your NovoLog® (insulin aspart [rDNA origin] injection) Community Star Story for the Chance to Win a Donation to the Charity of Your Choice!

Novo Nordisk, a world leader in diabetes care, is continuing the search for the first NovoLog® Community Stars. If you haven’t submitted yet, entries will be accepted through March 15. Patients with type 2 diabetes who are managing their blood sugar with NovoLog® (insulin aspart [rDNA origin] injection) are invited to visit and share how they’re giving back to their local communities.*

Finalists will each receive a $5,000 donation to a local diabetes-related organization of their choice. One ultimate NovoLog® Community Star will also receive a one-year online subscription to Weight Watchers® to help with their diabetes management.

Official Rules for submission are available by visiting If you have type 2 diabetes, or know someone who does, go online to share your inspiring story today!

Weight Watchers® is a registered trademark of Weight Watchers International, Inc.

About NovoLog® (insulin aspart [rDNA origin] injection)

Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

  • NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Who should not use NovoLog®?

  • Do not use NovoLog® if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

What should I tell my healthcare provider before taking NovoLog®?

  • About all of your medical conditions, including liver or kidney problems.
  • If you are pregnant, breastfeeding, or plan to do either.
  • About all prescription and nonprescription medicines you take, including supplements, as your dose may need to change.

How should I take NovoLog® (insulin aspart [rDNA origin] injection)?

  • Eat a meal within 5 to 10 minutes after using NovoLog®, a fast-acting insulin, to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after your injection or bolus pump infusion.
  • Do not mix NovoLog® with any other insulin when used in a pump or with any insulin other than NPH when used with injections by syringe.
  • Do not change your dose or type of insulin unless you are told to by your healthcare provider.
  • Do not share needles, insulin pens, or syringes.
  • Check your blood sugar levels as directed by your healthcare provider.

What should I consider while using NovoLog®?

  • Alcohol, including beer and wine, may affect your blood sugar.

Be careful when driving a car or operating machinery. You may have difficulty concentrating or reacting if you have low blood sugar. Talk to your healthcare provider if you often have low blood sugar or no warning signs of low blood sugar.
What are the possible side effects of NovoLog®?

  • Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.
  • Serious allergic reactions may occur. Get medical help right away, if you develop a rash over your whole body, have trouble breathing, a fast heartbeat, or sweating.
  • Other side effects include injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, swelling of your hands and feet, vision changes, low potassium in your blood, and weight gain.

NovoLog® is a registered trademark of Novo Nordisk A/S.

Please visit for Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

NovoLog® is a prescription medication.

*Certain restrictions apply. See official rules for entry information.

© 2013 Novo Nordisk   All rights reserved.   0113-00013265-1  February 2013

Leave a Reply

Your email address will not be published. Required fields are marked *